Lee H, Li D, Prior T, Casto B C, Weghorst C M, Shuler C F, Milo G E
Department of Medical Biochemistry, Ohio State University, Columbus, USA.
Cell Biol Toxicol. 1997 Oct;13(6):419-34. doi: 10.1023/a:1007419810705.
Human tumor cells have properties in vitro or in surrogate hosts that are distinct from those of normal cells, such as immortality, anchorage independence, and tumor formation in nude mice. However, different cells from individual tumors may exhibit some, but not all of these features. In previous years, human tumor cell lines derived from different tumor and tissue types have been studied to determine those molecular changes that are associated with the in vitro properties listed above and with tumorigenicity in nude mice. In the present study, seven cell lines derived from human tumors were characterized for p53 and ras mutations that may occur in SCC tumor phenotypes and for tumor formation in nude mice. This investigation was designed to examine whether co-occurrence of mutated ras and p53 lead to a malignant stage in the progression process. None of the seven cell lines contained mutations in the recognized "hot spots" of the p53 tumor suppressor gene, but four had a nonsense/splice mutation in codon 126 and a mutation in codon 12 of the H-ras gene. The remaining three cell lines had p53 mutations in intron 5, in codon 193, and a missense mutation in codon 126, respectively. Four of seven cell lines were nontumorigenic; two of these cell lines contained a nonsense p53-126 mutation and mutated ras; one had a missense mutation at codon 126 but no mutated ras; the the fourth had only a p53 mutation at codon 193. Two of the nontumorigenic cell lines were converted to tumorigenicity after treatment with methyl methanesulfonate or N-methyl-N'-nitro-N-nitrosoguanidine with no apparent additional mutations in either gene. Our analysis revealed that there was a high frequency of genetic diversity and mutations in both p53 and H-ras. There was also a lack of a causal relationship in the presence of mutations in p53 and the cells' ability to exhibit a malignant potential in nude mice.
人类肿瘤细胞在体外或替代宿主中具有与正常细胞不同的特性,如永生化、不依赖贴壁生长以及在裸鼠体内形成肿瘤。然而,来自单个肿瘤的不同细胞可能仅表现出部分而非全部这些特征。在过去几年中,人们对源自不同肿瘤和组织类型的人类肿瘤细胞系进行了研究,以确定那些与上述体外特性以及在裸鼠体内的致瘤性相关的分子变化。在本研究中,对源自人类肿瘤的七个细胞系进行了p53和ras突变特征分析,这些突变可能发生在鳞状细胞癌(SCC)肿瘤表型中,并对其在裸鼠体内形成肿瘤的情况进行了研究。本调查旨在检验ras和p53突变的同时出现是否会导致进展过程进入恶性阶段。七个细胞系中没有一个在p53肿瘤抑制基因的公认“热点”区域发生突变,但有四个在第126密码子处发生无义/剪接突变,并且在H-ras基因的第12密码子处发生突变。其余三个细胞系分别在第5内含子、第193密码子处发生p53突变,以及在第126密码子处发生错义突变。七个细胞系中有四个无致瘤性;其中两个细胞系含有p53第126密码子无义突变和ras突变;一个在第126密码子处有错义突变但无ras突变;第四个仅在第193密码子处有p53突变。在用甲磺酸甲酯或N-甲基-N'-硝基-N-亚硝基胍处理后,两个无致瘤性的细胞系转变为具有致瘤性,且两个基因中均未出现明显的额外突变。我们的分析表明,p53和H-ras基因中均存在高频的遗传多样性和突变。p53突变的存在与细胞在裸鼠体内表现出恶性潜能的能力之间也缺乏因果关系。